Compare RZLT & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RZLT | WSBF |
|---|---|---|
| Founded | 2010 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.7M | 288.1M |
| IPO Year | N/A | N/A |
| Metric | RZLT | WSBF |
|---|---|---|
| Price | $9.51 | $15.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 41.1K |
| Earning Date | 11-06-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 3.83% |
| EPS Growth | N/A | ★ 87.32 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $137,060,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.83 |
| Revenue Growth | N/A | ★ 2.87 |
| 52 Week Low | $2.22 | $11.61 |
| 52 Week High | $11.46 | $16.75 |
| Indicator | RZLT | WSBF |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 56.15 |
| Support Level | $9.34 | $15.11 |
| Resistance Level | $9.82 | $15.98 |
| Average True Range (ATR) | 0.66 | 0.29 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 9.36 | 59.77 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.